New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Alzheimer's medications, milestones and disease management

Alzheimer's medications, milestones and disease management

by Jeremy Deutchman,University of Southern CaliforniaCredit: Pixabay/CC0 Public DomainAlzheimer's disease and the urgent need for more effective treatments have been making headlines this ye
Neurology April 08,2024
Alzheimer's medications, milestones and disease management

Alzheimer's medications, milestones and disease management

by Jeremy Deutchman,University of Southern CaliforniaCredit: Pixabay/CC0 Public DomainAlzheimer's disease and the urgent need for more effective treatments have been making headlines this ye
Neurology April 08,2024
Signs of Alzheimer's disease may be detectable before significant symptoms are obvious

Signs of Alzheimer's disease may be detectable before significant symptoms are obvious

by University of GlasgowCredit: Pixabay/CC0 Public DomainHealthy people with a higher genetic risk of Alzheimer's disease may show differences in brain structure and in cognitive test scores
Neurology April 08,2024
Signs of Alzheimer's disease may be detectable before significant symptoms are obvious

Signs of Alzheimer's disease may be detectable before significant symptoms are obvious

by University of GlasgowCredit: Pixabay/CC0 Public DomainHealthy people with a higher genetic risk of Alzheimer's disease may show differences in brain structure and in cognitive test scores
Neurology April 08,2024
A common risk factor for Alzheimer's disease may predispose carriers to severe COVID-19

A common risk factor for Alzheimer's disease may predispose carriers to severe COVID-19

by University of HelsinkiCredit: Pixabay/CC0 Public DomainA study conducted at the University of Helsinki and the Helsinki University Hospital (HUS) suggests that the APOE4 allele may also increa
Neurology April 08,2024
A common risk factor for Alzheimer's disease may predispose carriers to severe COVID-19

A common risk factor for Alzheimer's disease may predispose carriers to severe COVID-19

by University of HelsinkiCredit: Pixabay/CC0 Public DomainA study conducted at the University of Helsinki and the Helsinki University Hospital (HUS) suggests that the APOE4 allele may also increa
Neurology April 08,2024
Genetic risk factors for Alzheimer's disease may be detectable even in young adults

Genetic risk factors for Alzheimer's disease may be detectable even in young adults

by American Academy of NeurologyCredit: CC0 Public DomainNew research shows that a genetic risk score may detect those at higher risk for Alzheimer's disease long before symptoms appear—even
Neurology April 08,2024
Genetic risk factors for Alzheimer's disease may be detectable even in young adults

Genetic risk factors for Alzheimer's disease may be detectable even in young adults

by American Academy of NeurologyCredit: CC0 Public DomainNew research shows that a genetic risk score may detect those at higher risk for Alzheimer's disease long before symptoms appear—even
Neurology April 08,2024
Blood-based biomarkers for Alzheimer's disease: Study in China

Blood-based biomarkers for Alzheimer's disease: Study in China

by Science China PressA total of 817 participants were recruited to evaluate potential alterations in blood-based biomarkers for AD among different clinical groups, including AD dementia, non-AD
Neurology April 08,2024
Blood-based biomarkers for Alzheimer's disease: Study in China

Blood-based biomarkers for Alzheimer's disease: Study in China

by Science China PressA total of 817 participants were recruited to evaluate potential alterations in blood-based biomarkers for AD among different clinical groups, including AD dementia, non-AD
Neurology April 08,2024
Alzheimer's and aducanumab: Unjust profits and false hopes

Alzheimer's and aducanumab: Unjust profits and false hopes

by The Hastings CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's disease raises at leas
Neurology April 08,2024
Alzheimer's and aducanumab: Unjust profits and false hopes

Alzheimer's and aducanumab: Unjust profits and false hopes

by The Hastings CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's disease raises at leas
Neurology April 08,2024
Alzheimer's research increasingly focused on links to sleep and other behaviors

Alzheimer's research increasingly focused on links to sleep and other behaviors

by ElsevierCredit: CC0 Public DomainSleep and other behavioral topics are growing within Alzheimer's disease research, according to a new report released today by Elsevier, a global informati
Neurology April 08,2024
Alzheimer's research increasingly focused on links to sleep and other behaviors

Alzheimer's research increasingly focused on links to sleep and other behaviors

by ElsevierCredit: CC0 Public DomainSleep and other behavioral topics are growing within Alzheimer's disease research, according to a new report released today by Elsevier, a global informati
Neurology April 08,2024
Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid aggregates

Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid aggregates

by Technical University MunichProposed mechanism and hypothetical models of IAPP/ACM nanofiber co-assembly versus IAPP amyloid self-assembly. The lower part, IAPP self-assembly into toxic oligome
Neurology April 08,2024
Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid aggregates

Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid aggregates

by Technical University MunichProposed mechanism and hypothetical models of IAPP/ACM nanofiber co-assembly versus IAPP amyloid self-assembly. The lower part, IAPP self-assembly into toxic oligome
Neurology April 08,2024
Alzheimer's disease research sheds new light on medication side effects

Alzheimer's disease research sheds new light on medication side effects

by Danielle Aiken,Western Sydney UniversityCredit: Unsplash/CC0 Public DomainA new study led by Western Sydney University has shed new light on the treatment of Alzheimer's disease, after re
Neurology April 08,2024
Alzheimer's disease research sheds new light on medication side effects

Alzheimer's disease research sheds new light on medication side effects

by Danielle Aiken,Western Sydney UniversityCredit: Unsplash/CC0 Public DomainA new study led by Western Sydney University has shed new light on the treatment of Alzheimer's disease, after re
Neurology April 08,2024
Diagnosis of Alzheimer's disease: Llama antibodies detect cerebral lesions

Diagnosis of Alzheimer's disease: Llama antibodies detect cerebral lesions

by Institut PasteurThe specific VHH antibody for plaques, labeled with a green fluorochrome, is injected into mice. The VHH travels along the blood vessels before marking the plaques in the brain. Pho
Neurology April 08,2024
Diagnosis of Alzheimer's disease: Llama antibodies detect cerebral lesions

Diagnosis of Alzheimer's disease: Llama antibodies detect cerebral lesions

by Institut PasteurThe specific VHH antibody for plaques, labeled with a green fluorochrome, is injected into mice. The VHH travels along the blood vessels before marking the plaques in the brain. Pho
Neurology April 08,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com